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Objectives. In this study we report our preliminary results and
intermediate-term follow-up (up to 3.5 years) of stent implanta-
tion for coarctation of the aorta (COA).
Background. Balloon angioplasty has gained acceptance as a
modality of treatment for COA. Some patients do not respond
optimally to balloon angioplasty alone. Balloon-expandable stents
have been used in pulmonary arteries and large systemic arteries
such as the femoroiliac vessels, with a significant improvement in
vessel patency and a reduction in the pressure gradient compared
with balloon angioplasty alone.
Methods. Nine patients (>10 years old) with COA in whom
balloon dilation alone was thought to be ineffective underwent
stent implantation. Seven patients had a previous operation or
balloon dilation, or both, to relieve their coarctation but had a
significant residual/recurrent gradient.
Results. At the time of stent implantation, the systolic and
mean gradients decreased from a mean (6SEM) of 37 6 7 and
14 6 3 mm Hg to 4 6 1 and 2 6 0.6 mm Hg, respectively (p <2
0.002). The coarctation diameter increased from a mean of 9 6 1
to 15 6 1 mm (p < 0.002). The patients have been followed for up
to 42 months (mean 18, median 13) with no complications; the
stents remain in position with no fracture. One patient underwent
further successful dilation 3 years after stent implantation be-
cause of an exercise-induced gradient. No other intervention has
been required. The systolic gradient at latest follow-up is 7 6
2 mm Hg. Only two (a 44-year old with diabetes and a 50-year old
with long-standing hypertension) of five patients previously re-
quiring antihypertensive treatment still remain on medications
for blood pressure control.
Conclusions. The use of stents in COA is a feasible alternative
to surgical repair or balloon angioplasty in selected patients with
an effective gradient reduction. Intermediate-term follow-up
shows excellent gradient relief, with no complications in this
group of patients.
(J Am Coll Cardiol 1997;30:1847–52)
©1997 by the American College of Cardiology
Balloon dilation has gained acceptance in the treatment of
coarctation of the aorta (COA). It has been advocated as the
therapy of choice in postoperative coarctation (1–4) and as an
acceptable alternative to surgical repair in native coarctation
(5,6). However, a significant number of patients develop
recoarctation after balloon angioplasty (7–9). To improve the
results of balloon angioplasty, patients .10 years of age with
COA, evaluated at the Cleveland Clinic since 1993, were
considered for stent implantation. We report our initial expe-
rience and short- to intermediate-term follow-up of these
patients.
Methods
Patients. All patients undergoing stent implantation for
COA at the Cleveland Clinic Foundation between January
1993 and November 1996 were included in the study. There
were nine patients (two males and seven females) between 14
and 63 years old. Their weight ranged from 47 to 133 kg
(median 61).
Catheterization technique. Informed consent was obtained
from all the patients, or the parent, if the patient was a minor.
The study was initiated after approval of the Institutional
Review Board of the Cleveland Clinic Foundation. After 1
year, stent implantation was no longer considered investiga-
tional and only the patient’s (or parent’s) informed consent
was required. All patients underwent routine cardiac catheter-
ization under general anesthesia. Hemodynamic data, includ-
ing systolic and mean gradients, and angiographic measure-
ment of the coarctation site, the proximal aorta and the
descending aorta at the level of the diaphragm were acquired.
With the aid of a guide catheter, a long stiff guide wire was
placed across the stenotic area. This was used to position a
10F, 11F or 12F sheath and dilator across the coarctation site.
The dilator was then removed and a Palmaz stent (P308, 3 cm
long and 3.4 mm unexpanded diameter; Johnson & Johnson
Interventional Systems Co.), mounted on a balloon dilation
catheter (12, 15, 18 or 20 mm Z-med or Tyshack, NuMed,
Inc.), was advanced inside the sheath to the stenotic area. The
balloon size chosen was the nearest size equal to the diameter
of the transverse aortic arch not to exceed the diameter of the
descending aorta at the level of the diaphragm (maximum
20 mm). The long sheath was withdrawn to expose the
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balloon-mounted stent, which was carefully positioned at the
coarctation site. The balloon was then inflated using the
recommended pressure (4 to 5 atm). In some instances, further
inflation of the proximal and distal ends of the balloon was
done to ensure flaring of the stent ends. Repeat hemodynamic
and angiographic data were acquired (Fig. 1).
Anticoagulation. We have maintained our patients on as-
pirin for at least 1 year after the procedure to avoid platelet
aggregation. Because this is a high pressure, high flow area, it
was not thought necessary to use warfarin to anticoagulate the
patients.
Follow-up. All patients had follow-up at 1 month and
yearly thereafter. This included a complete history and physical
examination, blood pressure measurements in all extremities
and a chest roentgenogram. An echocardiogram and an exer-
cise test were obtained at the discretion of the referring
cardiologist. To assess any residual stenosis across the coarc-
tation, the higher value of the arm and leg blood pressure
measurement gradients or the Doppler-derived corrected gra-
dients (10) was used.
Data analysis. The pre-stent and post-stent implantation
data were compared using the paired Student t test. A p value
#0.05 was considered statistically significant. The data are
expressed as the mean value 6 SEM (except for the follow-up
period, which is expressed as the median value because of the
skewed distribution). Clinical success was considered to be a
gradient reduction across the coarctation segment to
#20 mm Hg at rest.
Results
A total of 10 procedures involving stent implantation were
performed in nine patients (Table 1); one patient required
further balloon dilation of the stent 3 years after implantation.
Seven patients had previous surgical repair of the coarctation;
six had previous balloon dilation of the coarctation. Balloon
angioplasty was performed immediately before stent implan-
tation in four patients. When hemodynamic assessment dem-
onstrated the persistence of an unacceptable gradient despite
adequate dilation, a decision was made to implant a stent. Two
patients with native coarctation had stent placement as an
initial procedure; one patient with severe scoliosis and restric-
tive lung disease was considered high surgical risk and the
other patient refused surgical intervention. The balloon dila-
tion size was 15 mm in four patients, 18 mm in three, 20 mm in
two and 12 mm in one. The last patient is a young adult of
small build whose descending aorta measured 11 mm. The
systolic and mean gradients (Table 2) decreased significantly
from 37 6 7 to 4 6 1 mm Hg and 14 6 3 to 2 6 0.6 mm Hg,
respectively, after stent implantation. The size of the coarcta-
tion site increased from 9 6 1 to 15 6 1 mm (p , 0.002). Two
patients had a hypoplastic distal transverse arch where a stent
Figure 1. A, Angiogram of the coarctation
before angioplasty. B, After balloon angio-
plasty, the coarctation size increased from 7
to 9.5 mm, with a residual gradient of
20 mm Hg. C, After stent implantation, there
was an increase in the coarctation size to
12 mm, with a decrease in the gradient to
4 mm Hg. See text for details.
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was placed with adequate gradient relief (Fig. 2). The end of
the stent extended slightly into the orifice of the left subclavian
artery or the left common carotid artery in these patients.
Immediate post-stent angiography showed normal flow to both
vessels.
Follow-up. No patient has been lost to follow-up. Detailed
medical evaluations are available up to 42 months after the
procedure (average 18, median 13). Chest roentgenograms
have shown all stents to be in good position with no fracture or
dislodgment. No patient has reported any symptoms of dizzi-
ness, numbness, unexplained weakness or claudications. There
were no episodes suggestive of thromboembolic phenomena.
No clinically detectable femoral artery problems were encoun-
tered either immediately after the procedure or at follow-up.
Before stent implantation, five patients had hypertension
requiring antihypertension treatment. Only two patients (a
45-year old diabetic patient and a 50-year old patient with
long-standing hypertension) still require antihypertension
treatment despite elimination of the gradient after the stent
implantation. One patient who previously had exercise-
induced hypertension had a normal blood pressure exercise
response 1 year after stent implantation. Another patient, with
a 15-mm Hg gradient at rest, who is a competitive athlete,
developed an 82-mm Hg gradient at peak exercise testing at 3-














1 14/F 61 COA, HTN, hypoplastic transverse arch Patch graft, then tube graft 1 1 BB
2 17/F 48 COA distal to left subclavian, mild
HTN
End to end anastomosis 1 1 None
3 18/F 61 Severe AS, coarctation End to end anastomosis, Ross
procedure
1 of AS, COA 1 None
4 63/M 54 COA, HTN, scoliosis, restrictive lung
disease
None 2 2 ACEI
5 45/F 133 COA, HTN, diabetes mellitus End to end anastomosis 1 2 BB
6 28/F 71 COA, HTN End to end anastomosis, PDA
ligation
1 1 BB
7 19/F 62 AS, AI, COA, hypoplastic transverse
arch
End to end anastomosis 1 of AS, COA 2 None
8 18/M 47 COA, VSD, CVA after surgical repair VSD closure, two COA
surgical repairs, including
end to end anastomosis and
subclavian turndown
2 2 None
9 50/F 70 COA, HTN None 2 2 ACEI, CCB
ACEI 5 angiotensin-converting enzyme inhibitor; AI 5 aortic insufficiency; AS 5 aortic stenosis; BB 5 beta-blocker; CCB 5 calcium channel blocker; COA 5
coarctation of the aorta; CVA 5 cerebrovascular accident; F 5 female; HTN 5 hypertension; M 5 male; PDA 5 patent ductus arteriosus; Pt 5 patient; VSD 5
ventricular septal defect; 1 5 balloon angioplasty or valvuloplasty, or both; 2 5 no previous balloon angioplasty.
Table 2. Hemodynamic Findings Before and After Stent Implantation
Pt No.


























1 9 0.6 0.57 44 21 13 0.87 0.83 8 4 0† 40
2 7 0.41 0.41 30 25 12 0.71 0.71 4 5 18 42
3 9 0.45 0.5 36 10 14 0.7 0.78 8 0 9 34
4 4 0.28 0.34 86 12 16 1 1.2 0 0 0 21
5 12 0.52 0.57 35 12 17 0.74 0.81 12 2 16 8
6 8 0.47 0.62 36 32 14 0.82 1.1 2 0 0 13
7 10 0.47 0.5 18 4 17 0.89 0.89 2 2 9 1
8 9 0.84 0.84 17 4 11 1 1 0 1 12 1
9 15 0.56 0.58 28 14 19 0.7 0.73 2 2 0 1
Mean 6
SEM
9 6 1 0.5 6 0.03 0.55 6 0.05 37 6 7 14 6 3 15 6 1* 0.82 6 0.04* 0.89 6 0.06* 4 6 1* 2 6 0.6* 7 6 2* 18 (13)‡
*p , 0.002 versus pre-stent values. †Value given is postballoon redilation 3 years after stent implantation. ‡Because of the skewed distribution of the follow-up
period, average (and median) values are given. Follow-up gradients are the higher of the blood pressure measurements or the Doppler-estimated gradients. Cath 5
catheterization; Coa 5 coarctation; DAo 5 descending aorta at the level of the diaphragm; Prox Ao 5 proximal aorta.
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years follow-up. At 38 months after stent implantation, she
underwent a repeat cardiac catheterization and stent redilation
using an 18-mm balloon with elimination of the rest gradient
(15-mm balloon was used in the initial implantation). A
follow-up stress test revealed a maximal gradient of 27 mm Hg
at peak exercise. This patient’s stent spanned across the left
subclavian artery and part of the left common carotid artery at
initial implantation because of a hypoplastic transverse arch.
Repeat angiography 3 years later demonstrated normal flow to
both the left subclavian and left common carotid arteries (Fig.
3). At latest follow-up, the mean (6SEM) rest gradient in all
patients across the coarctation site, taking the higher value of
the blood pressure measurements or Doppler-estimated cor-
rected gradients, is 7 6 2 mm Hg (median 9, ,20 in all
patients).
Discussion
Balloon-expandable stents have been used in the vascular
system since the mid-1980s (11–14). Shortly after the initial
successful experience with balloon-expandable stents in the
iliac arteries, these stents were introduced in the management
of stenotic lesions in congenital heart disease both postopera-
tively and as an alternative to surgical repair (15). Their
usefulness has been demonstrated in a number of stenotic
lesions. In 1993, O’Laughlin et al. (16) reported the early and
intermediate-term follow-up of stents implanted in the pulmo-
nary arteries and the venous system to relieve obstruction.
Their results demonstrated that the stents retained their
efficacy and continued to provide beneficial effects with no
significant complications. The use of stents has been expanded
Figure 2. A, The angiogram before stent de-
ployment demonstrates the presence of coarc-
tation with a hypoplastic transverse arch. B,
After stent deployment, the angiogram demon-
strates the position of the stent extending to
cover part of the transverse arch. There is no
angiographic evidence of flow obstruction in
the arch vessels.
Figure 3. A, Coarctation and mild hypoplasia of
the distal transverse arch evident before stent
deployment. Despite the interposition of a tube
graft (open arrow), a 44-mm Hg gradient per-
sisted. B, Stent deployed partially covering the
left subclavian and common carotid arteries.
The gradient decreased to 8 mm Hg, and the
size of the coarctation increased from 9 to
13 mm. C, Three years later, the angiogram
demonstrates normal flow in the left subclavian
and common carotid arteries. Note the pres-
ence of a small neointimal layer. LC 5 left
common carotid artery; LSC 5 left subclavian
artery. See text for details.
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to involve other stenotic lesions, such as right ventricle to
pulmonary artery homografts (17). Animal studies in 1994
demonstrated the feasibility of stents in treating experimental
coarctation. Follow-up of animals with stents showed contin-
ued relief of the coarctation gradient with no evidence of
intraluminal thrombosis (18). Encouraging initial and short-
term results have been reported in a small number of patients
who underwent stent implantation for COA (19–21). Our
results show that the beneficial effects appear to persist up to
3.5 years after stent implantation.
Recoarctation after balloon angioplasty has been seen in
18% to 31% of patients with native coarctation (7,8) and in 9%
to 80% (9,22) of those with postoperative coarctation. Recur-
rence was found to depend on the age of the patient, the
nature of the lesion and size of the balloon used. Late
follow-up of patients treated with balloon angioplasty showed
that 32% of the patients with recurrent coarctation had not
had adequate gradient relief (,20 mm Hg) at the initial
angioplasty procedure, despite an adequate balloon/isthmus
ratio (8). Two possible mechanisms of recurrence include
elastic recoil of the tissue and the presence of long segment
narrowing, especially the transverse aortic arch. Intravascular
stents can maintain the patency of a stenotic lesion by elimi-
nating the elastic recoil of the tissue and can extend over a
relatively long segment of stenosis.
In this study, we report our initial experience and short- to
mid-term follow-up of nine patients. In four of our patients,
initial balloon angioplasty performed in the same cardiac
catheterization failed to satisfactorily eliminate the gradient
(Fig. 1). In these patients the stenosis was dilatable, but recoil
of the dilated segment resulted in persistence of an unaccept-
able gradient. Stents provide support to prevent recoil of the
coarctation segment; thus, long-term enlargement of the ste-
notic site is achieved. As more experience and confidence in
this procedure are gained, it may be possible to select patients
who should have a stent implanted without immediate balloon
angioplasty beforehand. This will give the advantages of short-
ening the procedure and avoiding wire manipulation in a
freshly dilated segment (21).
Extension of a stent into the orifices of the branches of the
aortic arch is a concern, as the struts can cause obstruction to
the flow in major vessels. In adult-size patients, however, the
struts of a dilated stent are very small relative to the diameter
of the subclavian and carotid arteries. In two of our patients
with a hypoplastic distal transverse arch, a stent extended
slightly over the orifice of the left common carotid artery or left
subclavian artery, or both. Immediate post-stent angiography
demonstrated no flow obstruction to any of these vessels (Fig.
2B and 3B). Repeat angiography 3 years after stent implanta-
tion in one of these patients demonstrated no flow obstruction
in either vessel (Fig. 3C). No patient has complained of any
symptoms suggestive of limb ischemia or decreased cerebral
blood flow. Despite the encouraging results, longer follow-up
of these patients is required before definite conclusions can be
made.
Redilation of stents. The incidence of significant restenosis
in previously placed stents in the branch pulmonary arteries
has been reported to be low (3%) (23). Redilation of stents in
the branch pulmonary arteries has been successful up to 3
years after implantation. However, there continues to be
concern about the frequency of success or safety of redilation
of previously implanted stents. The data on redilation of stents
in animal models of coarctation remain conflicting. In one
study (18), redilation of stented coarctation 6 months after
initial implantation was successful with no untoward sequelae.
However, in a canine puppy model for coarctation, Mendel-
sohn et al. (24) reported aortic dissection in two of seven
animals during redilation of previously implanted stents. The
success of redilation of stents in coarctation sites 3 years after
implantation has not been previously demonstrated in humans.
Because the results of redilation are not yet established, the
selection of patients in our center is limited to those in whom
the stent can be dilated at the initial implantation to a diameter
large enough that the growth of the patient would not
necessarily result in relative stent stenosis. In this study, one
patient underwent successful redilation 3 years after implan-
tation with no complications. The balloon used was 18 mm
(initial implantation was done using a 15-mm balloon). This
allowed further expansion of the stent and elimination of a
residual waist.
Conclusions. In selected patients with COA, stent implan-
tation may be a feasible alternative to relieve stenosis.
Follow-up of these patients up to 3.5 years has demonstrated
continued gradient relief.
We thank Carolyn Apperson-Hansen, MStat for reviewing the statistical analysis
and rendering advice.
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